A previously unknown chemical structure, 6-desmethyl-6-ethylerythromycin A (6-ethylErA), was produced through directed genetic manipulation of the erythromycin (Er)-producing organism Saccharopolyspora erythraea. In an attempt to replace the methyl side chain at the C-6 position of the Er polyketide backbone with an ethyl moiety, the methylmalonate-specific acyltransferase (AT) domain of the Er polyketide synthase was replaced with an ethylmalonate-specific AT domain from the polyketide synthase involved in the synthesis of the 16-member macrolide niddamycin. The genetically altered strain was found to produce ErA, however, and not the ethyl-substituted derivative. When the strain was provided with precursors of ethylmalonate, a small quantity of a macrolide with the mass of 6-ethylErA was produced in addition to ErA. Because substrate for the heterologous AT seemed to be limiting, crotonyl-CoA reductase, a primary metabolic enzyme involved in butyryl-CoA production in streptomycetes, was expressed in the strain. The primary macrolide produced by the reengineered strain was 6-ethylErA.
Erythromycin (Er) is a broad-spectrum macrolide antibiotic produced by Saccharopolyspora erythraea. The backbone of the molecule is a 14-member macrocyclic ring ( Fig. 1 ) that is produced through the sequential condensation of one molecule of propionyl-CoA and six molecules of methylmalonylCoA by a modular polyketide synthase (PKS). This enzyme complex comprises three large multifunctional polypeptides, DEBS1, DEBS2, and DEBS3, each of which contains two modules, and, in the case of DEBS1, a loading domain to initiate synthesis of the polyketide chain (1, 2) . Each module contains the enzymatic activities necessary for one condensation and subsequent reduction of the extender to the growing chain. Selection of the appropriate extender unit is accomplished by the acyltransferase (AT) domain present in each module (3) .
Recently, genetic engineering has joined synthetic chemistry in the production of novel macrolide structures. Hybrid PKSs have been constructed through the replacement of AT domains with those that specify different starter or extender units (3) (4) (5) (6) . These manipulations have resulted in the production of Er derivatives lacking methyl groups at C-10 and C-12 (5) and those incorporating the branched chain starter units of avermectin biosynthesis (6) . To date, however, there have been no manipulations that allow the methyl side chains of Er to be replaced by ethyl groups. This type of modification would be useful in expanding the structural diversity of hybrid polyketides produced by combinatorial biosynthesis.
Niddamycin (Nd) is a 16-member macrolide with an ethyl side chain at C-6 (Fig. 1) . The module 5 AT, which is believed to be responsible for incorporation of the ethyl side chain into the polyketide backbone, was identified by sequence analysis of the Nd PKS genes (7) . In this paper we describe the construction of a hybrid PKS through the replacement of a methylmalonyl-specific AT of the Er PKS with that of the ethylmalonyl-specific AT of the Nd PKS. This substitution alone, however, was not sufficient to produce an Er derivative with an ethyl side chain; additional manipulations of the carboxylic acid precursor pools were necessary to generate the desired compound.
MATERIALS AND METHODS
Strains, Plasmids, and Media. The wild-type Er producer is S. erythraea ER720 (8) . Plasmid pWHM3 (9) is an Escherichia coli-Streptomyces shuttle vector that is maintained in S. erythraea only when it contains heterologous DNA for chromosomal integration. Plasmid pDPE81 is a derivative of pKAS37 (10) in which a 1.7-kb BglII fragment containing the hygromycin resistance marker was inserted into the BglII site of pKAS37. E. coli DH5␣ (Life Technologies, Gaithersburg, MD) was the host used for plasmid construction and isolation. Liquid cultures of S. erythraea strains were grown in SGGP (11) for production of protoplasts and SCM (5) for metabolite or enzyme analysis. Plate cultures of S. erythraea strains were grown on R3M medium (5) . Thiostrepton (Ts)-resistant strains of S. erythraea were grown in 25 g͞ml and 10 g͞ml Ts for plate and liquid cultures, respectively.
Plasmid pEAT4 ( Fig. 2A) was constructed as follows. Cosmid pAIBX85, a pWHM3 derivative containing DNA from modules 3 and 4 of the Er PKS (corresponding to nucleotides 979-9349; GenBank accession no. M63677), was used to clone DNA flanking eryAT4. The 5Ј flanking region was isolated by digesting pAIBX85 with MscI and BstEII (nucleotides 4247-6033), treating with the Klenow fragment of DNA polymerase, and ligating the fragment into the SmaI site of pUC19 to generate pUC͞5Ј flank. An AvrII site was engineered 13 bp downstream of the BstEII site by PCR amplification of a 306-bp region of DNA from the PmlI site (nucleotide 5739) to 12 bp 3Ј of the BstEII site (nucleotide 6045). The engineered AvrII site does not change the Pro-Arg residues encoded by this region (Fig. 2B) . A BamHI site was also included on the PCR primer just downstream of the AvrII site. The resulting fragment was digested with PmlI and BamHI and cloned into the PmlI͞BamHI site of pUC͞5Ј flank, replacing the native se-quence and resulting in vector pUC͞5Ј flank͞AvrII. The 3Ј flanking DNA was isolated by digesting pAIXB85 with PmlI and MscI (nucleotides 6999 and 8977), treating with the Klenow enzyme, and ligating the fragment into the SmaI site of pUC19, generating vector pUC͞3Ј flank. nidAT5 was isolated by PCR amplification of cosmid 13f5 (7), which contains DNA spanning module 5 of the Nd PKS cluster. The 5Ј oligonucleotide was designed to create an AvrII site 12 nucleotides upstream of the beginning of the nidAT5 domain (nucleotide 25290; GenBank accession no. AF016585) and to place the amino acid sequence Pro-Arg-Lys-Pro in front of nidAT5 to correspond to the sequence that is found upstream of the eryAT4 domain. The 3Ј oligonucleotide generated an FseI site at the end of the nidAT5 domain (nucleotide 26284, GenBank accession no. AF016585), resulting in a conservative Val to Ala change. A BamHI site was also incorporated after the FseI site. The fragment was digested with AvrII and BamHI and ligated into AvrII͞BamHI-digested pUC͞5Ј flank͞AvrII, creating vector pUC͞5Ј flank͞nidAT5. The 3Ј flanking DNA was then cloned onto the 3Ј end of nidAT5 by first digesting pUC͞3Ј flank with FseI and BamHI, gel purifying the 1920-bp fragment, and ligating it into FseI͞BamHI-digested pUC͞5Ј flank͞nidAT5, creating vector pUC͞nidAT5͞C6-flank. To generate pEAT4, the nidAT5͞flanking DNA cassette was isolated from pUC͞nidAT5͞C6-flank by digestion with EcoRI and HindIII and then ligated to EcoRI͞HindIII-digested pWHM3.
Plasmid pDPE-ccr ( Fig. 3 ) was constructed as follows. The Streptomyces collinus crotonyl-CoA reductase (Ccr) gene (ccr) was subcloned from plasmid pZYB3 (12) by digestion with XbaI and BamHI, which releases ccr and the upstream T7 ribosomal binding site. This fragment was treated with the Klenow enzyme and ligated into the polylinker of pDPE81 that had been digested with EcoRI and treated with the Klenow enzyme. The polylinker of pDPE81 is in the center of a 10-kb fragment of S. erythraea chromosomal DNA, which directs integration into the chromosome at a site that does not seem to affect Er production. Plasmid pDPE-ccr was designed so that the ccr gene expressed from the ermE* promoter (13) and the Ts-resistance marker are left behind in the chromosome following a double-crossover event.
Genetic Manipulations. Standard molecular biology techniques were performed as described (14) . Enzymes and reagents were purchased from Life Technologies. Protoplast transformation and marker replacement in S. erythraea were performed as described (5) . One microgram of plasmid DNA was routinely used for protoplast transformations. Putative transformants were grown in SGGP medium containing 10 g͞ml Ts to confirm resistance. For chromosomal eviction of pEAT4, transformants were passaged twice in SGGP medium without Ts, cells were plated for spores, and individual colonies arising from spores were screened for Ts sensitivity. Electroporation was performed as described (15) by using 1 g of pDPE-ccr DNA. Because the plasmid is unstable when integrated into the S. erythraea chromosome, two consecutive platings on Ts-containing R3M plates results in resolution and eviction of plasmid sequences. PCR and Southern hybridization were as described (7). Ccr Assay. Seed cultures of S. erythraea grown in SCM and S. collinus grown in medium A (16) were diluted 5-fold into SCM and medium A, respectively, and grown for 48 h at 30°C. Cells were harvested, opened with a French pressure cell, centrifuged to obtain cell-free extracts, and assayed spectrophotometrically for Ccr activity as described (16) . One unit of Ccr activity is defined as 1 mol of NADPH oxidized in 1 min.
Isolation and Identification of Metabolites. Small-scale (milliliters) isolation of metabolites from S. erythraea, TLC, and MS analysis were performed as described (5) . Large-scale isolation for compound identification was as follows. Fermentations were conducted in 42-liter LH fermentation series 2000 stainless steel vessels (LH Fermentation, Maidenhead, UK). Each fermentor was charged with 30 liters of a medium consisting of 1.5% soluble starch, 2.2% soybean flour, 0.2% CaCO 3 , 0.15% brewer's yeast (Wind Gap Farms, Baconton, GA), 0.102% MgSO 4 ⅐7H 2 O, 0.0027% FeSO 4 ⅐7H 2 O, and 1% soybean oil. Sterilization was at 121°C and 15 psi (1 psi ϭ 6.89 kPa). A two-step seed protocol was used. Vegetative growth from a frozen stock of S. erythraea strain EAT4-ccr was inoculated at 1.5% into a 500-ml Erlenmeyer flask containing 100 ml of the following medium: 1.5% glucose monohydrate͞1% soluble starch͞1% Soytone (Difco)͞0.9% yeast extract (Difco)͞0.21% Mops͞0.001% Ts. For the second step, a 2-liter Erlenmeyer flask containing 600 ml of the same medium was inoculated at 5% with the first-step growth. Both steps were incubated at 28°C on a rotary shaker at 225 rpm for 48 h. The fermentor was inoculated at 5% with the second-step seed growth. Fermentor temperature was controlled at 32°C, agitation was 250 rpm, aeration was 1 vol⅐vol Ϫ1 ⅐min
Ϫ1
, and head pressure was 6 psi. Silicone antifoam was added at 0.01% initially and was available on demand. Harvest was at 108 h.
The fermentation broth (28 liters) was filtered, the pH was adjusted to 9 with NH 4 OH, and the broth was extracted with CH 2 Cl 2 (twice with 14 liters each). The combined extracts were concentrated, and the residue was partitioned between the two phases of the heptane͞methanol͞0.02 M K 2 HPO 4 system (pH 6; 1:1:1). The aqueous phase was evaporated, and the residue was dissolved in 0.05 M aqueous potassium phosphate buffer (100 ml), adjusted to pH 9 with NH 4 OH, and extracted twice with equal volumes of CH 2 Cl 2 . The CH 2 Cl 2 -soluble fraction (1.65 g) was separated by droplet countercurrent chromatography (100 vertical columns; 0.4 ϫ 24 cm) by using the upper layer from the hexane͞ethyl acetate͞0.02 M K 2 HPO 4 (pH 8; 1:1:1) system as the mobile phase. The fractions were analyzed by bioassay against Staphylococcus aureus and by 1 H NMR. The bioactive fractions that were shown to contain macrolides by NMR were pooled, dried (0.4 g), and chromatographed on a Sanki Engineering (Kyoto) HPLC centrifugal partition chromatograph by using the hexane͞ethyl acetate͞0.02 M K 2 HPO 4 (pH 6; 1:1:1) system. The active fraction was further purified by HPLC on C 18 -derivatized silica by using an acetonitrile͞ methanol͞0.01 M (CH 3 ) 4 NOH͞0.05 M KH 2 PO 4 (pH 6; 73:10:59:59) system. Two-dimensional NMR experiments, including double-quantum correlation, heteronuclear multiple quantum correlation, and heteronuclear multiple-bond correlation, performed in C 2 HCl 3 , were used for structure elucidation and the complete assignment of the 1 H and 13 
C NMR signals.
In Vitro Antibacterial Activity. Antibacterial activity was determined by the broth microdilution method (National Committee for Clinical Laboratory Standards (Villanova, PA) M7-A4, 1997), except that Brain Heart Infusion (Difco) broth was used as the test medium. Assays were incubated overnight at 35°C. Minimal inhibitory concentrations were defined as the lowest drug concentration (g͞ml) inhibiting bacterial growth.
RESULTS
Construction of S. erythraea EAT4. Plasmid pEAT4 was constructed to replace DNA encoding the AT domain of module 4 in the Er PKS (eryAT4) with DNA encoding the AT domain from module 5 of the Nd PKS (nidAT5) (7). S. erythraea ER720 protoplasts were transformed with pEAT4 DNA, and 10 transformants were obtained. Genomic DNA was extracted from one of the transformants for Southern analysis, in which probing with pWHM3 DNA confirmed the integration of pEAT4 at the appropriate location in the chromosome (data not shown). Nonselective growth to allow plasmid eviction through a double-crossover event yielded 96 colonies, of which 9 were found to be Ts sensitive. Southern analysis of the 9 clones showed that 3 had nidAT5 DNA sequences in place of eryAT4 chromosomal sequences, and the remaining 6 had segregated to wild type (data not shown).
Characterization of S. erythraea EAT4.
To analyze the Er derivatives produced by S. erythraea EAT4, the three isolates and four of the wild-type segregants were grown in SCM medium for 4 d. The four wild-type segregants produced spots indistinguishable in color and R f from the ErA standard. The three strains in which nidAT5 replaced the AT of module 4 of the Er PKS produced spots similar in R f and color to the wild-type segregants, but the spots were much less intense (data not shown).
To determine the mass of the compound produced by S. erythraea EAT4, the supernatant of a 50-ml SCM culture of one of the isolates was extracted with ethyl acetate. The extract was subjected to TLC, but only the edges of the plate were sprayed with anisaldehyde to locate the region of interest. A 1-cm band of resin was scraped from the unsprayed portion of the plate at the R f of ErA. The resin was extracted twice with 500 l of an ethyl acetate͞methanol (2:1) solution, and the organic phase was dried and then analyzed by electrospray ionization MS. Surprisingly, the mass of the protonated molecular ion of the compound was observed at m͞z 734, which corresponds to the mass of ErA, not an ethyl-substituted ErA derivative.
Feeding of Ethylmalonyl-CoA Precursors to S. erythraea EAT4. One hypothesis for the failure of S. erythraea EAT4 to produce an ethyl-substituted derivative is that ethylmalonylCoA, the substrate for the nidAT5, is lacking. To test this hypothesis, cells were grown for 4 d in SCM medium containing precursor compounds, and ethyl acetate extracts of the cultures were analyzed. When either 50 mM butanol or 50 mM butyrate was added to the medium, a second spot running slightly faster than the R f of ErA was seen. Butyrate-fed cultures (Fig. 4A) produced about a 1:1 ratio of the two spots, whereas the butanol-fed culture produced more of the ErAlike spot (data not shown). Addition of 10 mM ethylmalonate failed to produce significant amounts of either of the two spots described above. However, addition of 10 mM diethylethylmalonate was found to yield much more of the faster migrating compound than that seen with the other precursor compounds tested and very little compound migrating at the R f of ErA (Fig. 4A) . Cells grown in unsupplemented SCM medium produced only material migrating like ErA.
To characterize the newly synthesized compound, extracts of the butyrate-and the diethylethylmalonate-fed cultures were subjected to TLC, the region of interest was scraped from the plate and reextracted for electrospray ionization MS. The results showed that the butyrate-fed culture of S. erythraea EAT4 produced approximately equal amounts of compounds with protonated molecular ions at m͞z 734 and 748. The 748 species is consistent with an additional methylene group on ErA, e.g., with an ethyl group replacing a methyl group on the Genetic Manipulation of Ethylmalonyl-CoA Levels in S. erythraea EAT4. Successful production of an Er derivative with a mass consistent with the addition of an ethyl side chain by butyrate-and diethylmalonate-fed S. erythraea EAT4 suggested that the levels of ethylmalonyl-CoA, the likely substrate of the nidAT5, must be limiting. In streptomycetes, Ccr catalyzes the last step in the reductive biosynthesis of butyrylCoA from two molecules of acetyl-CoA (12) . Because butyrylCoA can then be carboxylated to form ethylmalonyl-CoA, the possibility that Ccr could be used to increase the levels of the ethyl-substituted Er derivative was investigated. The ccr gene of S. collinus was expressed from the strong ermE* promoter at a site unlinked to the Er biosynthetic cluster in the S. erythraea EAT4 chromosome. Plasmid pDPE-ccr was electroporated into S. erythraea EAT4. About 40 Ts-resistant colonies were obtained, of which 7 were confirmed to be stable transformants. Genomic DNA was isolated from 2 of the transformants for Southern analysis. Probing with the S. collinus ccr gene confirmed that both isolates carried the gene at the expected location in the chromosome (data not shown). The strain was named S. erythraea EAT4-ccr.
To assess expression levels of the ccr gene, Ccr activity of S. erythraea EAT4-ccr was compared with that of S. erythraea EAT4 (parental strain) and wild-type S. collinus. We found ( Table 1 ) that, although there was no detectable activity in the S. erythraea strain without the ccr gene, S. erythraea EAT4-ccr had about 20 times the relative activity of the wild-type S. collinus strain from which the gene originated.
To determine the effect of the ccr gene on production of an ethyl-substituted Er derivative, ethyl acetate extracts of supernatants of 4-d SCM-grown cultures of the EAT4 strains with and without the ccr gene were examined (Fig. 4B) . TLC analysis of 10 ml of extracted cells demonstrated that EAT4 without the ccr gene produced a spot that migrated with ErA, whereas EAT4-ccr produced a spot that migrated faster than the ErA spot, with no ErA-like material visible.
Extracts were also analyzed by electrospray ionization MS. The EAT4 strain produced a compound with a protonated molecular ion at m͞z 734, indicating ErA production. The EAT4-ccr strain produced a compound with a mass of 748, which is consistent with the production of the 6-ethylErA. No compound with a mass of 734 (ErA) was detected in extracts of this strain.
Structural Analysis and Biological Activity of Compound Produced by S. erythraea EAT4-ccr. The structure of 6-ethylErA was confirmed by spectroscopic methods. The high resolution fast atom bombardment MS analysis of the sample gave an M ϩ H Numbering of carbon atoms of Er is as described (17) . by two-dimensional NMR. The stereospecificity of the ethyl moiety was found to be the same as that of the methyl group present at C-6 of ErA (Fig. 1) . The 1 H and 13 C NMR assignments are shown in Table 2 .
Antibacterial activity of 6-ethylErA was compared with that of ErA against a panel of S. aureus, Staphylococcus epidermidis, Streptococcus pyogenes, and Enterococcus faecium strains from the Abbott culture collection. Although 6-ethylErA does retain biological activity, it was found to be 15 to 60 times less potent than ErA against these strains. Representative minimal inhibitory concentrations (g͞ml) for 6-ethylErA and ErA, respectively, were as follows: S. aureus (4 and 0.06), S. epidermidis (4 and 0.12), E. faecium (4 and 0.12), and S. pyogenes (1 and 0.06).
DISCUSSION
In this work we have shown that an ethylmalonate AT can be substituted for a methylmalonate AT to produce a hybrid PKS that synthesizes the predicted macrolide product, 6-ethylErA. This suggests that Er analogs containing ethyl substitutions at positions other than C-6 or that ethyl analogs of other macrolides, such as rifamycin or rapamycin, can be prepared in a similar fashion by using the ethylmalonate-specific AT from the Nd PKS.
One key feature for the successful generation of 6-ethylErA was availability of ethylmalonyl-CoA as substrate for the ethylmalonate-specific AT of the Nd PKS in S. erythraea. This AT clearly demonstrates a relaxed specificity by reacting with both ethylmalonyl-CoA and methylmalonyl-CoA. In S. erythraea EAT4, the desired product could be obtained only by boosting the levels of ethylmalonyl-CoA by either precursor feeding or expression of Ccr, an enzyme involved in butyrylCoA biosynthesis. These results suggest that ethylmalonylCoA derived from butyryl-CoA is not available at sufficient levels to compete with methylmalonyl-CoA for the ethylmalonate-specific AT. Ccr activity is not detectable in S. erythraea and attempts to detect a ccr gene in this organism by hybridization with the S. collinus ccr gene have failed (results not shown). In contrast, the ccr gene appears to be present in most streptomycetes (16) , and in certain cases it appears to be clustered with antibiotic biosynthetic gene clusters. For example, a ccr homolog has been located in the biosynthetic cluster for tylosin (18) , another 16-member macrolide with an ethyl side chain. Southern analysis of cosmid clones containing Nd biosynthetic genes also indicates that a ccr homolog may reside close to the Nd PKS (unpublished results).
It was demonstrated previously (5) that production of desmethyl Er derivatives by replacement of methylmalonatespecific ATs of the Er PKS with malonate-specific ATs from Streptomyces hygroscopicus and Streptomyces venezuelae was successful only in Er modules 1 and 2 (corresponding to C-12 and C-10 of Er, respectively) and did not give rise to a detectable polyketide when placed in module 4. In contrast, we successfully produced ethyl-substituted Er by replacement of the methylmalonate-specific AT of Er module 4 with the ethylmalonate-specific AT from the Nd cluster. In fact, in S. erythraea expressing the S. collinus ccr gene, replacements in modules 1 through 4 with the ethylmalonate-specific AT produced compounds with electrospray ionization mass spectra consistent with production of ethyl substitutions for methyl groups at C-12, C-10, C-8, and C-6, respectively. However, those in modules 5 and 6 did not produce compounds of mass 748 (data not shown). It is not known whether failure to produce the predicted compounds was caused by physical distortion of the PKS or its mRNA, inability of the PKS to process certain altered growing chains, or some structural instability of the macrolide itself because of the introduced change. Thus, even though genetic information may be present for the production of novel compounds, it is still not possible to predict which substitutions will yield detectable levels of product.
It has also been demonstrated that the malonyl-specific ATs can be distinguished from methylmalonyl-specific ATs through sequence alignments (3) . By using this strategy, Ruan et al. (5) predicted that an AT from an unidentified PKS of S. hygroscopicus was a malonyl-specific AT, and they used it successfully to produce desmethyl Er derivatives. The Nd ethylspecific AT was found to cluster with methylmalonyl-specific ATs (7) in similar AT alignments. This similarity may explain why methylmalonate was used as a substrate by nidAT5 in S. erythraea EAT4 to produce ErA when ethylmalonyl-CoA was not available.
Finally, structural determination by NMR not only confirmed the presence of the ethyl side chain on the Er derivative produced by S. erythraea EAT4 but also showed that the absolute configuration at this chiral center is the same as that in ErA. In Er biosynthesis, epimerization is required at C-6 because the PKS uses (2S)-methylmalonyl-CoA for chain extension (19) . It is unclear whether the cognate epimerization occurs when ethylmalonate is used in the synthesis of 6-ethylErA because the stereochemistry of the ethylmalonate incorporated at C-6 is not known.
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